Tetraphase Pharmaceuticals (TTPH) shares were down more than 1% Monday after it reported its net loss narrowed from a year earlier, but missed expectations, while revenue fell.
Tetraphase reported a net loss of $13.5 million, or $0.53 per share, compared to a net loss of $2.8 million, or $1.51 per share, for the same period in 2013. The Street expected a loss of $0.44 per share.
Revenue was $2.5 million, down from $2.7 million a year prior. Revenue estimates were not available.
TTPH trades in a 52-week range of $7.02 to $17.74.
Latest posts by Kevin Calderon (see all)
- Samsung Galaxy S8 Comes with Major Design Changes, Leaks Confirm - Feb 17, 2017
- Could Pollinating Drones Help Bees In This Natural Process? - Feb 11, 2017
- Latest Rumors About the iPhone 8 Predict Facial Recognition - Jan 20, 2017